Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The complex physiology of Cellvibrio japonicus xylan degradation relies on a single cytoplasmic β-xylosidase for xylo-oligosaccharide utilization.

Blake AD, Beri NR, Guttman HS, Cheng R, Gardner JG.

Mol Microbiol. 2018 Mar;107(5):610-622. doi: 10.1111/mmi.13903. Epub 2018 Jan 8.

2.

Synthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.

Joseph SC, Blackman BA, Kelly ML, Phillips M, Beaury MW, Martinez I, Parronchi CJ, Bitsaktsis C, Blake AD, Sabatino D.

J Pept Sci. 2014 Sep;20(9):736-45. doi: 10.1002/psc.2665. Epub 2014 Jun 15.

PMID:
24931620
3.

Solid-phase synthesis, characterization and RNAi activity of branch and hyperbranch siRNAs.

Maina A, Blackman BA, Parronchi CJ, Morozko E, Bender ME, Blake AD, Sabatino D.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5270-4. doi: 10.1016/j.bmcl.2013.08.033. Epub 2013 Aug 12.

PMID:
23988358
4.

Function and expression of somatostatin receptors of the endocrine pancreas.

Strowski MZ, Blake AD.

Mol Cell Endocrinol. 2008 May 14;286(1-2):169-79. doi: 10.1016/j.mce.2008.02.007. Epub 2008 Feb 17. Review.

PMID:
18375050
5.

Sgbeta1, a novel locust (Schistocerca gregaria) non-alpha nicotinic acetylcholine receptor-like subunit with homology to the Drosophila melanogaster Dbeta1 subunit.

Jones AK, Marshall J, Blake AD, Buckingham SD, Darlison MG, Sattelle DB.

Invert Neurosci. 2005 Nov;5(3-4):147-55. Epub 2005 Oct 24.

PMID:
16177887
6.

Somatostatin increases voltage-gated K+ currents in GH3 cells through activation of multiple somatostatin receptors.

Yang SK, Parkington HC, Blake AD, Keating DJ, Chen C.

Endocrinology. 2005 Nov;146(11):4975-84. Epub 2005 Aug 4.

PMID:
16081634
7.

Somatostatin: a hormone for the heart?

Badway AC, Blake AD.

Curr Vasc Pharmacol. 2005 Apr;3(2):125-31. Review.

PMID:
15853632
8.

Somatostatin regulates intracellular signaling in human carotid endothelial cells.

Badway AC, West FM, Tente SM, Blake AD.

Biochem Biophys Res Commun. 2004 Jul 9;319(4):1222-7.

PMID:
15194497
9.

Differential desensitization of somatostatin receptor subtypes in atT-20 cells.

Mazza FC, Blake AD.

Protein Pept Lett. 2004 Apr;11(2):141-7.

PMID:
15078202
10.

Delineating somatostatin's neuronal actions.

Blake AD, Badway AC, Strowski MZ.

Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):153-60. Review.

PMID:
15078190
11.

Dipyridamole is neuroprotective for cultured rat embryonic cortical neurons.

Blake AD.

Biochem Biophys Res Commun. 2004 Feb 6;314(2):501-4.

PMID:
14733934
12.

Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells.

Yu X, Mao X, Blake AD, Li WX, Chang SL.

J Pharmacol Exp Ther. 2003 Aug;306(2):447-54. Epub 2003 May 16.

PMID:
12754318
13.

Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.

Strowski MZ, Kohler M, Chen HY, Trumbauer ME, Li Z, Szalkowski D, Gopal-Truter S, Fisher JK, Schaeffer JM, Blake AD, Zhang BB, Wilkinson HA.

Mol Endocrinol. 2003 Jan;17(1):93-106.

PMID:
12511609
14.

Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells.

Strowski MZ, Dashkevicz MP, Parmar RM, Wilkinson H, Kohler M, Schaeffer JM, Blake AD.

Neuroendocrinology. 2002 Jun;75(6):339-46.

PMID:
12065886
16.

The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states.

Di Salvo J, Koch GE, Johnson KE, Blake AD, Daugherty BL, DeMartino JA, Sirotina-Meisher A, Liu Y, Springer MS, Cascieri MA, Sullivan KA.

Eur J Pharmacol. 2000 Dec 8;409(2):143-54.

PMID:
11104827
17.
18.

Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.

Parmar RM, Chan WW, Dashkevicz M, Hayes EC, Rohrer SP, Smith RG, Schaeffer JM, Blake AD.

Biochem Biophys Res Commun. 1999 Sep 24;263(2):276-80.

PMID:
10491284
19.

Fentanyl and its analogs desensitize the cloned mu opioid receptor.

Bot G, Blake AD, Li S, Reisine T.

J Pharmacol Exp Ther. 1998 Jun;285(3):1207-18.

PMID:
9618424
20.

Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist.

Bot G, Blake AD, Li S, Reisine T.

J Pharmacol Exp Ther. 1998 Jan;284(1):283-90.

PMID:
9435189
21.

Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding.

Bot G, Blake AD, Li S, Reisine T.

J Neurochem. 1998 Jan;70(1):358-65.

22.

Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.

Bot G, Blake AD, Li S, Reisine T.

Mol Pharmacol. 1997 Aug;52(2):272-81.

PMID:
9271350
23.

Differential agonist regulation of the human kappa-opioid receptor.

Blake AD, Bot G, Li S, Freeman JC, Reisine T.

J Neurochem. 1997 May;68(5):1846-52.

24.

Differential opioid agonist regulation of the mouse mu opioid receptor.

Blake AD, Bot G, Freeman JC, Reisine T.

J Biol Chem. 1997 Jan 10;272(2):782-90.

25.

Molecular regulation of opioid receptors.

Blake AD, Bot G, Tallent M, Law SF, Li S, Freeman JC, Reisine T.

Receptors Channels. 1997;5(3-4):231-5. Review.

PMID:
9606728
26.
27.

Localization in the nervous system of Drosophila melanogaster of a C-terminus anti-peptide antibody to a cloned Drosophila muscarinic acetylcholine receptor.

Harrison JB, Chen HH, Blake AD, Huskisson NS, Barker P, Sattelle DB.

J Neuroendocrinol. 1995 May;7(5):347-52.

PMID:
7550280
28.

Drosophila nervous system muscarinic acetylcholine receptor: transient functional expression and localization by immunocytochemistry.

Blake AD, Anthony NM, Chen HH, Harrison JB, Nathanson NM, Sattelle DB.

Mol Pharmacol. 1993 Oct;44(4):716-24.

PMID:
8232221
29.

Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy.

Cassileth BR, Lusk EJ, Guerry D, Blake AD, Walsh WP, Kascius L, Schultz DJ.

N Engl J Med. 1991 Apr 25;324(17):1180-5.

31.

Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.

Strader CD, Dixon RA, Cheung AH, Candelore MR, Blake AD, Sigal IS.

J Biol Chem. 1987 Dec 5;262(34):16439-43. Erratum in: J Biol Chem 1988 Feb 25;263(6):3050.

32.

Synthetic segments of the mammalian beta AR are preferentially recognized by cAMP-dependent protein kinase and protein kinase C.

Blake AD, Mumford RA, Strout HV, Slater EE, Strader CD.

Biochem Biophys Res Commun. 1987 Aug 31;147(1):168-73.

PMID:
2820394
33.
34.

The carboxyl terminus of the hamster beta-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration.

Strader CD, Sigal IS, Blake AD, Cheung AH, Register RB, Rands E, Zemcik BA, Candelore MR, Dixon RA.

Cell. 1987 Jun 19;49(6):855-63.

PMID:
3034435
35.

Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.

Dixon RA, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, Strader CD.

Nature. 1987 Mar 5-11;326(6108):73-7.

PMID:
2881211
36.
37.

Role of Ca2+ in secretagogue-stimulated breakdown of phosphatidylinositol in rat pancreatic islets.

Axen KV, Schubart UK, Blake AD, Fleischer N.

J Clin Invest. 1983 Jul;72(1):13-21.

38.

ABDOMINAL AORTIC ANEURYSM WITH VENA CAVAL FISTULA. REPORT OF A CASE WITH OBSERVATIONS ON AN UNUSUAL CLINICAL COURSE.

VANDERVEER JB, ROBINSON HJ, BLAKE AD Jr.

Arch Intern Med. 1964 Oct;114:551-4. No abstract available.

PMID:
14184647
39.

TREATMENT OF GASTROINTESTINAL DISORDERS WITH A COMBINATION OF TRIFLUOPERAZINE AND ISOPROPAMIDE.

BLAKE AD Jr.

Clin Med (Northfield). 1963 Aug;70:1461-5. No abstract available.

PMID:
15446040
40.

Clinical evaluation of a new laxative.

BLAKE AD Jr.

Am J Dig Dis. 1948 Oct;15(10):336-9. No abstract available.

PMID:
18884577
41.

An acid citrate-dextrose solution with low water volume and low dextrose concentration.

STRUMIA MM, BLAKE AD Jr, McGRAW JJ Jr.

J Clin Invest. 1947 Jul;26(4):678-85. No abstract available.

PMID:
20255646
42.

The preservation of erythrocytes left over from plasma preparation.

STRUMIA MM, BLAKE AD Jr, WICKS WA.

J Clin Invest. 1947 Jul;26(4):672-7. No abstract available.

PMID:
20255645
43.

The preservation of whole blood.

STRUMIA MM, BLAKE AD Jr, WICKS WA.

J Clin Invest. 1947 Jul;26(4):667-71. No abstract available.

PMID:
20255644
44.

AN ACID CITRATE-DEXTROSE SOLUTION WITH LOW WATER VOLUME AND LOW DEXTROSE CONCENTRATION.

Strumia MM, Blake AD, McGraw JJ, Dolan MM, Colwell ML.

J Clin Invest. 1947 Jul;26(4):678-86. No abstract available.

45.

THE PRESERVATION OF ERYTHROCYTES LEFT OVER FROM PLASMA PREPARATION.

Strumia MM, Blake AD, Wicks WA, Donnelly MK, Dolan MM, Colwell ML.

J Clin Invest. 1947 Jul;26(4):672-7. No abstract available.

46.

THE PRESERVATION OF WHOLE BLOOD.

Strumia MM, Blake AD, Wicks WA, Donnelly MK, Dolan MM, Colwell ML.

J Clin Invest. 1947 Jul;26(4):667-71. No abstract available.

47.

The diuretic effect of globin in chronic glomerulonephritis.

STRUMIA MM, BLAKE AD Jr, CORNMAN HD.

J Am Med Assoc. 1946 Jul 27;131:1033-5. No abstract available.

PMID:
20991365
48.

The use of a modified globin from human erythrocytes in hypoproteinemias.

STRUMIA MM, BLAKE AD, et al.

Am J Med Sci. 1946 Jan;211:51-61. No abstract available.

PMID:
21009770

Supplemental Content

Loading ...
Support Center